Meg Begur

Associate
mbegur@cooley.com
Full contact info

About Meg

Meg Begur practices corporate and securities law. She advises technology and life sciences companies at all stages of their growth cycle, as well as venture capital funds and investment banking firms. She represents clients on a wide range of matters including formations, corporate governance, venture financings, public offerings, and SEC reporting. 

View full bio

Experience

Encord Announces 30 Million Series B

Encord Announces 30 Million Series B

August 13, 2024

Cooley advised Encord, a data development platform for multimodal artificial intelligence, on its $30 million Series B financing.

Read more

Related contacts

Josh Seidenfeld
Partner, Palo Alto
Lindsy Solanki
Special Counsel, Palo Alto
Meg Begur
Associate, Washington, DC
Joseph A. Kroon
Associate, Palo Alto
Christopher Kimball
Partner, Washington, DC
Jonathan Rivinus
Partner, Colorado
John Sellers
Partner, Palo Alto
Nicola Squire
Partner, London
Christine Graham
Special Counsel, London
Rebecca Ross
Special Counsel, Washington, DC
Sarah Oliai
Associate, Washington, DC
Shelby Saunders
Associate, New York
Kevin Gurley
Quantitative Analyst, New York

Related Practices & Industries

Emerging Companies
Artificial Intelligence
CFIUS
Antitrust and Competition
Tax
Compensation and Benefits

Snap $750 Million Convertible Senior Notes Offering

Snap $750 Million Convertible Senior Notes Offering

May 13, 2024

Cooley advised Snap, a technology company, on its $750 million convertible senior notes offering due 2030, which includes the option for initial purchasers to purchase an additional $100 million aggregate principal amount of notes.

Read more

Related contacts

Eric Jensen
Vice Chair, Palo Alto
David Peinsipp
Partner, San Francisco
Noel Ripberger-Scheick
Associate, Palo Alto
Meg Begur
Associate, Washington, DC
Alanna Anderson
Associate, Palo Alto
Victoria Comesañas
Associate, Palo Alto
Bill Boyle
Paralegal Specialist, Palo Alto
Francis Wheeler
Partner, Colorado

Related Practices & Industries

Emerging Companies
Capital Markets
Technology
Internet and Social Media

Kimia Therapeutics Closes $55 Million Series A

Kimia Therapeutics Closes $55 Million Series A

December 19, 2023

Cooley advised Kimia Therapeutics on its $55 million Series A financing. Partner Josh Seidenfeld led the Cooley team advising Kimia Therapeutics, which is a drug discovery platform that uncovers novel biological insights through precision chemistry and machine learning.

Read more

Related contacts

Josh Seidenfeld
Partner, Palo Alto
Karen Gustavson
Associate, Seattle
Rachel Robichaux
Associate, Palo Alto
Phoebe Huang
Associate, Seattle
Meg Begur
Associate, Washington, DC
Colleen Badgley
Partner, Seattle

Related Practices & Industries

Emerging Companies
Venture Capital
Biotechnology
Life Sciences

Biote Agrees to Combine With SPAC Haymaker Acquisition Corp. III

Biote Agrees to Combine With SPAC Haymaker Acquisition Corp. III

December 16, 2021

Cooley advised Biote, a medical practice-building business within the hormone optimization space, on its definitive business combination agreement with special purpose acquisition company (SPAC) Haymaker Acquisition Corp III. Lawyers Michal Berkner and Jarrett Burks led the Cooley team advising Biote.

Related contacts

Jarrett Burks
Associate, London
Ryan Sansom
Partner, Boston
Meg Begur
Associate, Washington, DC
Timothy Shapiro
Partner, Palo Alto
Eileen Marshall
Partner, Washington, DC
Jeff Goldman
Special Counsel, Palo Alto
Sonia Nath
Partner, Washington, DC
Michael Tollini
Partner, Washington, DC
Phil Mitchell
Partner, New York
Wyatt Kernell
Associate, Colorado
Mischi a Marca
Partner, San Francisco
Kathleen Goodhart
Partner, San Francisco
Ehijele Olumese
Associate, Santa Monica
Francis Wheeler
Partner, Colorado
Claire Keast-Butler
Co-Partner in Charge – London, London
Andrew Epstein
Special Counsel, Seattle
Todd Gluth
Partner, San Diego
Joseph Lockinger
Special Counsel, Washington, DC
Stacey A. Bradford
Special Counsel, Washington, DC
David Hopkins
Special Counsel, Colorado
Ross Eberly
Partner, Santa Monica

Related Practices & Industries

Mergers and Acquisitions
Technology
Medtech
Life Sciences
Emerging Companies
Tax
Debt Finance
Labor and Employment
Healthcare
Commercial Litigation
Compensation and Benefits
Intellectual Property

Exscientia – $510.4 Million IPO

Exscientia – $510.4 Million IPO

October 6, 2021

Cooley advised Exscientia, an AI-driven pharmatech company based in Oxford, United Kingdom, on its $510.4 million initial public offering, including concurrent private placements to SoftBank and the Bill & Melinda Gates Foundation. Partners David Boles, Claire Keast-Butler, Div Gupta and Marc Recht led the Cooley team advising Exscientia.

Read more

Related contacts

Claire Keast-Butler
Co-Partner in Charge – London, London
Div Gupta
Partner, New York
Marc Recht
Partner, Boston
David Wilson
Partner, London
Chris Stack
Partner, London
Dayne Brown
Associate, New York
Meg Begur
Associate, Washington, DC
Nicola Squire
Partner, London
Jack Jones
Associate, London
Tom Goodman
Partner, London
Paula Holland
Partner, London
Aaron Pomeroy
Partner, Colorado
Calvin Lee
Associate, New York
Courtney Thorne
Partner, London

Related Practices & Industries

Capital Markets
Public Companies
Emerging Companies
Life Sciences
Artificial Intelligence
Digital Health
Medtech
Tax
Labor and Employment
Intellectual Property
Patent Counseling and Prosecution – Life Sciences
View more

Admissions and credentials

California

Not admitted to practice in Washington, DC

Supervised by active members of the Washington, DC Bar